Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathy Nguyen

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Plos One|October 12, 2012
A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodentsJian Luo, Gayathri Swaminath, Sean P Brown, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2005
Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapyQian Gong, Qinglin Ou, Shiming Ye, et al.
Plos One|November 17, 2011
AMG 837: a novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodentsDaniel C-H Lin, Jane Zhang, Run Zhuang, et al.
Bioorganic & Medicinal Chemistry Letters|January 6, 2012
AMG 837: a potent, orally bioavailable GPR40 agonistJonathan B Houze, Liusheng Zhu, Ying Sun, et al.
Nature Medicine|April 19, 2024
Risk-based lung cancer screening performance in a universal healthcare settingMartin C Tammemägi, Gail E Darling, Heidi Schmidt, et al.
Biomedicines|January 22, 2021
The Biology of VasopressinSamantha Sparapani, Cassandra Millet-Boureima, Joshua Oliver, et al.
Microbiology (Reading, England)|December 5, 2019
Metabolic networks of the human gut microbiotaSusannah Selber-Hnatiw, Tarin Sultana, W Tse, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Plos One|October 12, 2012
A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodentsJian Luo, Gayathri Swaminath, Sean P Brown, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2005
Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapyQian Gong, Qinglin Ou, Shiming Ye, et al.
Plos One|November 17, 2011
AMG 837: a novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodentsDaniel C-H Lin, Jane Zhang, Run Zhuang, et al.
Bioorganic & Medicinal Chemistry Letters|January 6, 2012
AMG 837: a potent, orally bioavailable GPR40 agonistJonathan B Houze, Liusheng Zhu, Ying Sun, et al.
Nature Medicine|April 19, 2024
Risk-based lung cancer screening performance in a universal healthcare settingMartin C Tammemägi, Gail E Darling, Heidi Schmidt, et al.
Biomedicines|January 22, 2021
The Biology of VasopressinSamantha Sparapani, Cassandra Millet-Boureima, Joshua Oliver, et al.
Microbiology (Reading, England)|December 5, 2019
Metabolic networks of the human gut microbiotaSusannah Selber-Hnatiw, Tarin Sultana, W Tse, et al.
Pageof 4